Key result
This review summarizes normal platelet function, the effects of abnormal function, and thrombocytopenia, focusing solely on platelet hemostatic properties.
This review summarizes normal platelet function and the clinical implications of qualitative and quantitative platelet disorders, particularly regarding hemostasis and bleeding symptoms.
Recognizing mucocutaneous bleeding prompts platelet disorder evaluation; review leaves open pediatric management trials.
After vascular injury and exposure of subendothelial matrix proteins to the intravascular space, mediators of hemostasis are triggered and allow for clot formation and restoration of vascular integrity. Platelets are the mediators of primary hemostasis, creating a platelet plug and allowing for initial cessation of bleeding. Platelet disorders, qualitative and quantitative, may result in bleeding signs and symptoms, particularly mucocutaneous bleeding such as epistaxis, bruising, petechiae, and heavy menstrual bleeding. Increasing evidence suggests that platelets have functional capabilities beyond hemostasis, but this review focuses solely on platelet hemostatic properties. Herein, normal platelet function as well as the effects of abnormal function and thrombocytopenia are reviewed.
No takes yet. Share an insight, caveat, or question.
Kristina M. Haley (2020) conducted a review in Platelet disorders. This review summarizes normal platelet function, the effects of abnormal function, and thrombocytopenia, focusing solely on platelet hemostatic properties.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: